43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
13:05 UTC
|
TEVA
Teva Pharmaceutical Industries
|
◎ Target | Glen Santangelo ★★★☆☆ #1449 | Overweight | $40.00→ $42.00+5.0% |
|
Aug 12
13:05 UTC
|
SMCI
Super Micro Computer
|
◎ Target | Sajal Dogra not yet tracked | Buy | $45.00→ $51.00+13.3% |
|
Aug 12
13:05 UTC
|
SFD
Smithfield Foods
|
◎ Target | Benjamin Theurer ★★★☆☆ #2166 | Overweight | $32.00→ $31.00-3.1% |
|
Aug 12
13:05 UTC
|
SEPN
Septerna
|
◎ Target | Derek Archila ★★★☆☆ #2101 | Overweight | $48.00→ $50.00+4.2% |
|
Aug 12
13:05 UTC
|
RIG
Transocean
|
◎ Target | Eddie Kim ★★★☆☆ #2109 | Overweight | $8.00→ $7.00-12.5% |
|
Aug 12
13:05 UTC
|
PGNY
Progyny
|
◎ Target | Peter Warendorf ★★☆☆☆ #2462 | Equal Weight | $34.00→ $30.00-11.8% |
|
Aug 12
13:05 UTC
|
ONON
ON
|
◎ Target | Adrienne Yih ★★★☆☆ #1659 | Overweight | $46.00→ $42.00-8.7% |
|
Aug 12
13:05 UTC
|
NTRA
Natera
|
◎ Target | Subbu Nambi ★★★★☆ #353 | Buy | $290.00→ $360.00+24.1% |
|
Aug 12
13:05 UTC
|
NGNE
Neurogene
|
◎ Target | Debjit Chattopadhyay ★★★☆☆ #1736 | Buy | $69.00→ $81.00+17.4% |
|
Aug 12
13:05 UTC
|
MSFT
Microsoft
|
◎ Target | Michael Turrin ★★★☆☆ #1608 | Overweight | $650.00→ $700.00+7.7% |
|
Aug 12
13:05 UTC
|
LEGN
Legend Biotech
|
◎ Target | Etzer Darout ★★★☆☆ #2240 | Overweight | $80.00→ $78.00-2.5% |
|
Aug 12
13:05 UTC
|
LBRX
LB Pharmaceuticals
|
◎ Target | Malcolm Hoffman not yet tracked | Outperform | $46.00→ $54.00+17.4% |
|
Aug 12
13:05 UTC
|
LAMR
Lamar Advertising
|
◎ Target | Steven Cahall ★★★☆☆ #1660 | Equal Weight | $150.00→ $151.00+0.7% |
|
Aug 12
13:05 UTC
|
ETOR
eToro Group
|
◎ Target | Dan Dolev ★★★☆☆ #1424 | Outperform | $60.00→ $52.00-13.3% |
|
Aug 12
13:05 UTC
|
EROK
EagleRock Land
|
◎ Target | Theresa Chen ★★☆☆☆ #2332 | Overweight | $25.00→ $27.00+8.0% |
|
Aug 12
13:05 UTC
|
EE
Excelerate Energy
|
◎ Target | Praneeth Satish ★★☆☆☆ #2632 | Equal Weight | $37.00→ $38.00+2.7% |
|
Aug 12
13:05 UTC
|
CTEV
Claritev
|
◎ Target | Stan Berenshteyn ★★★☆☆ #1707 | Equal Weight | $22.00→ $30.00+36.4% |
|
Aug 12
13:05 UTC
|
CRWV
CoreWeave
|
◎ Target | Michael Turrin ★★★☆☆ #1608 | Overweight | $155.00→ $160.00+3.2% |
|
Aug 12
13:05 UTC
|
CRM
Salesforce
|
◎ Target | Michael Turrin ★★★☆☆ #1608 | Equal Weight | $200.00→ $205.00+2.5% |
|
Aug 12
13:05 UTC
|
COGT
Cogent Biosciences
|
◎ Target | Michael Schmidt ★★★☆☆ #2261 | Buy | $45.00→ $52.00+15.6% |
|
Aug 12
13:05 UTC
|
CCAP
Crescent Capital BDC
|
◎ Target | Finian O'Shea ★★★★☆ #635 | Equal Weight | $12.00→ $11.00-8.3% |
|
Aug 12
13:05 UTC
|
CAVA
CAVA Group
|
◎ Target | Logan Reich ★★☆☆☆ #2472 | Outperform | $90.00→ $95.00+5.6% |
|
Aug 12
13:05 UTC
|
CAH
Cardinal Health
|
◎ Target | Stephen Baxter ★★★☆☆ #1471 | Overweight | $245.00→ $277.00+13.1% |
|
Aug 12
13:05 UTC
|
BCSF
Bain Capital Specialty Finance
|
◎ Target | Finian O'Shea ★★★★☆ #635 | Equal Weight | $13.00→ $12.00-7.7% |
|
Aug 12
13:05 UTC
|
BCAX
Bicara Therapeutics
|
◎ Target | Eva Fortea Verdejo ★★★★☆ #486 | Equal Weight | $16.00→ $23.00+43.8% |
|
Aug 12
13:05 UTC
|
ACM
AECOM
|
◎ Target | Adam Seiden ★★☆☆☆ #2525 | Equal Weight | $90.00→ $73.00-18.9% |
|
Aug 12
12:08 UTC
|
VSTS
Vestis
|
◎ Target | Andrew Wittmann ★★★★☆ #356 | Neutral | $15.00→ $16.00+6.7% |
|
Aug 12
12:08 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Arthur He not yet tracked | Buy | $125.00→ $90.00-28.0% |
|
Aug 12
12:08 UTC
|
UAMY
United States Antimony
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $11.75→ $9.25-21.3% |
|
Aug 12
12:08 UTC
|
TTAN
ServiceTitan
|
◎ Target | Joe Vruwink not yet tracked | Outperform | $94.00→ $101.00+7.4% |
|
Aug 12
12:08 UTC
|
SMC
Summit Midstream Partners
|
◎ Target | Jason Gabelman ★★★☆☆ #1763 | Buy | $39.00→ $43.00+10.3% |
|
Aug 12
12:08 UTC
|
SEPN
Septerna
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $40.00→ $60.00+50.0% |
|
Aug 12
12:08 UTC
|
QUIK
QuickLogic
|
◎ Target | Neil Young not yet tracked | Buy | $22.00→ $20.00-9.1% |
|
Aug 12
12:08 UTC
|
ONON
ON
|
◎ Target | Cristina Fernandez ★★☆☆☆ #2442 | Outperform | $51.00→ $43.00-15.7% |
|
Aug 12
12:08 UTC
|
ONON
ON
|
◎ Target | Jonathan Komp ★★★☆☆ #1074 | Outperform | $70.00→ $55.00-21.4% |
|
Aug 12
12:08 UTC
|
OMDA
Omada Health
|
◎ Target | Vikram Kesavabhotla ★★★★☆ #932 | Neutral | $15.00→ $25.00+66.7% |
|
Aug 12
12:08 UTC
|
NGNE
Neurogene
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $70.00→ $65.00-7.1% |
|
Aug 12
12:08 UTC
|
LITE
Lumentum
|
◎ Target | Vivek Arya ★★☆☆☆ #2662 | Neutral | $1,100.00→ $1,000.00-9.1% |
|
Aug 12
12:08 UTC
|
IPHA
Innate Pharma
|
◎ Target | Jeet Mukherjee ★★☆☆☆ #2364 | Buy | $8.00→ $9.00+12.5% |
|
Aug 12
12:08 UTC
|
HBT
HBT Financial
|
◎ Target | firm only | Outperform | $40.00→ $44.00+10.0% |
|
Aug 12
12:08 UTC
|
EXOD
Exodus Movement
|
◎ Target | Gareth Gacetta not yet tracked | Overweight | $14.00→ $15.00+7.1% |
|
Aug 12
12:08 UTC
|
ETOR
eToro Group
|
◎ Target | Nathan Frankovitz not yet tracked | Overweight | $61.00→ $53.00-13.1% |
|
Aug 12
12:08 UTC
|
ETOR
eToro Group
|
◎ Target | John Todaro ★★☆☆☆ #2292 | Buy | $66.00→ $53.00-19.7% |
|
Aug 12
12:08 UTC
|
ERAS
Erasca
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2493 | Buy | $18.00→ $22.00+22.2% |
|
Aug 12
12:08 UTC
|
ELE
Elemental Royalty
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $32.50→ $33.00+1.5% |
|
Aug 12
12:08 UTC
|
CRWV
CoreWeave
|
◎ Target | Brett Knoblauch ★★★☆☆ #1708 | Overweight | $167.00→ $176.00+5.4% |
|
Aug 12
12:08 UTC
|
CRWV
CoreWeave
|
◎ Target | Rob Oliver not yet tracked | Outperform | $100.00→ $130.00+30.0% |
|
Aug 12
12:08 UTC
|
CLMT
Calumet
|
◎ Target | firm only | Hold | $34.00→ $40.00+17.6% |
|
Aug 12
12:08 UTC
|
CAVA
CAVA Group
|
◎ Target | Andrew M. not yet tracked | Buy | $100.00→ $85.00-15.0% |
|
Aug 12
12:08 UTC
|
CAH
Cardinal Health
|
◎ Target | Eric Coldwell ★★★☆☆ #1069 | Outperform | $251.00→ $274.00+9.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.